0001437749-23-002263.txt : 20230201
0001437749-23-002263.hdr.sgml : 20230201
20230201163642
ACCESSION NUMBER: 0001437749-23-002263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230130
FILED AS OF DATE: 20230201
DATE AS OF CHANGE: 20230201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horvath Susan
CENTRAL INDEX KEY: 0001322846
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39468
FILM NUMBER: 23577311
MAIL ADDRESS:
STREET 1: 4645 ITHACA LANE
CITY: PLYMOUTH
STATE: MN
ZIP: 55446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Panbela Therapeutics, Inc.
CENTRAL INDEX KEY: 0001029125
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870543922
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 712 VISTA BLVD #305
CITY: WACONIA
STATE: MN
ZIP: 55387
BUSINESS PHONE: 9524791196
MAIL ADDRESS:
STREET 1: 712 VISTA BLVD #305
CITY: WACONIA
STATE: MN
ZIP: 55387
FORMER COMPANY:
FORMER CONFORMED NAME: Sun BioPharma, Inc.
DATE OF NAME CHANGE: 20150911
FORMER COMPANY:
FORMER CONFORMED NAME: Cimarron Medical, Inc.
DATE OF NAME CHANGE: 20150602
FORMER COMPANY:
FORMER CONFORMED NAME: CIMARRON SOFTWARE INC
DATE OF NAME CHANGE: 19961217
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-01-30
0001029125
Panbela Therapeutics, Inc.
PBLA
0001322846
Horvath Susan
712 VISTA BLVD #305
WACONIA
MN
55387
1
V.P. of Finance & CFO
Common Stock
2023-01-30
4
P
0
4444
A
17880
D
Warrants (right to buy)
2.75
2023-01-30
4
P
0
8888
0
A
2023-01-30
2028-01-30
Common Stock
8888
8888
D
Reported securities purchased as one share of common stock and one warrant to purchase two shares of common stock for a combined price of $2.25 per share and warrant.
On or after March 1, 2023, holder may elect an "alternative cashless exercise" pursuant to which they would receive an aggregate number of shares of common stock equal to 75% of the aggregate number of shares that would be issuable upon a cash exercise.
/s/ Joshua L. Colburn, Attorney-in-Fact
2023-02-01